Author:
De la Garza-Salazar Fernando,Colunga-Pedraza Perla Rocío,Gómez-Almaguer David,García-Zárate Valeria Abigail,Gómez-De León Andrés
Funder
Universidad Autonoma de Nuevo Leon
Subject
Cancer Research,Oncology,Hematology
Reference28 articles.
1. Azacitidine and venetoclax in previously untreated acute myeloid leukemia;DiNardo;N. Eng. J. Med.,2020
2. to therapy for acute myeloid leukemia in the developing world: barriers and solutions;Meillon;Curr. Oncol. Rep.,2020
3. Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome;Mabrey;Blood Adv.,2020
4. Orbital myeloid sarcoma treated with low-dose venetoclax and a potent cytochrome P450 inhibitor;De la Garza;J. Oncol. Pharm. Pract.,2022
5. Cytochrome P450 inhibition to decrease dosage and costs of venetoclax and ibrutinib: a proof-of-concept case study;De la Garza;Br. J. Clin. Pharmacol.,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献